Är det här rätt verktyg?

Så använder GovHub AI

Annonser

5 träffar, senast publicerade först. Se marknaden för träffarna

  1. Health status assessment of rodents

    Stockholms universitet · 2026-09-09 · 2 000 000 SEK · Tilldelning

    Stockholm University maintains a core facility for research in laboratory rodents (mice and rats). The purpose of this procurement is to obtain a supplier for reliable health status assessments of the colony, using both swabs and samples from sentinels and/or other sources such as filters. The suppl…

  2. Health status assessment of rodents

    Stockholms universitet · 2026-02-11 · sista anbudsdag 2026-03-11 · 2 000 000 SEK · Upphandling

    Stockholm University maintains a core facility for research in laboratory rodents (mice and rats). The purpose of this procurement is to obtain a supplier for reliable health status assessments of the colony, using both swabs and samples from sentinels and/or other sources such as filters. The suppl…

  3. DNA-extraction and genotyping of fish

    Stockholms universitet · 2025-05-02 · 6 000 000 SEK · Tilldelning

    The assignment concerns DNA extraction and genotyping of fish. The purpose is to map and monitor genetic diversity in stocks of these species in Swedish waters. The genotyping is needed partly to carry out assignments from the Swedish Agency for Marine and Water Management, but also for research (Fo…

  4. DNA-extraction and genotyping of fish

    Stockholms universitet · 2024-07-04 · sista anbudsdag 2024-08-06 · 6 000 000 SEK · Upphandling

    The assignment concerns DNA extraction and genotyping of fish. The purpose is to map and monitor genetic diversity in stocks of these species in Swedish waters. The genotyping is needed partly to carry out assignments from the Swedish Agency for Marine and Water Management, but also for research (Fo…

  5. in vivo mouse study for therapeutic toxins

    Stockholms universitet · 2024-03-21 · sista anbudsdag 2024-04-19 · 2 500 000 SEK · Upphandling

    The scope of this procurement is to establish a framework agreement for services regarding in vivo evaluations on the efficacy of newly developed botulinum neurotoxin-based therapeutic molecules.